syngo.CT LVO Detection

by Siemens Healthineers  · Based in United States → — We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably.
Emergency Medicine Neurology Radiology

Contact for pricing
Regulatory Status Disclosed

Overview

syngo.CT LVO Detection is an AI-powered post-processing software designed to analyze CT angiography (CTA) head images. It assists clinicians in prioritizing cases by detecting suspected large vessel occlusions (LVO) in specific brain vessels, including the ICA, M1, and M2 segments. The software runs on the syngo.via platform and is intended to aid in triage, helping medical professionals manage stroke patients more efficiently. Its output is for informational purposes only and is not intended for standalone diagnostic use or to alter original medical images.

Performance testing demonstrated a sensitivity of 90.6% and specificity of 88.8% for LVO detection, with a median processing time of 42 seconds. The tool is designed for patients 22 years or older, without certain contraindications such as old infarcts, other diseases impacting brain vasculature (e.g., brain tumors), metal artifacts, or surgical signs in the images.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered post-processing software for CT angiography analysis
  • Detects suspected large vessel occlusions (LVO) in ICA, M1, and M2 segments
  • Supports computer-aided triage and case prioritization
  • Runs on the Siemens syngo.via platform
  • Provides output for informational purposes only, not for standalone diagnosis
  • Does not alter original medical images
  • Demonstrated high sensitivity (90.6%) and specificity (88.8%) in performance testing
  • Fast processing time (median 42 seconds, under 110 seconds)
  • Intended for patients 22 years or older without specific contraindications

Use Cases

  • Prioritizing acute stroke cases based on suspected LVO detection
  • Assisting clinicians in efficient management of stroke patients
  • Facilitating early identification and notification of LVO to treatment teams
  • Improving stroke workflow metrics and potentially accelerating treatment decisions

What Physicians Need to Know

Brain CT Analysis
syngo.CT LVO Detection is a radiological post-processing application for the analysis of CT angiography (CTA) head images. It utilizes AI learning algorithms to analyze these images. The software supports computer-aided triage by identifying suspected large vessel occlusions (LVO) in the ICA, M1, and M2 segments. The output is intended for informational purposes and not for diagnostic use or image alteration.
Large Vessel Occlusion Detection
syngo.CT LVO Detection is designed to detect large vessel occlusions (LVO) in the ICA, M1, and M2 segments of the brain. It provides reproducible detection of LVOs on contrast-enhanced CT examinations of the head for patients suspected of having stroke-related circulation occlusion. The software uses AI learning algorithms for this detection.
Triage Prioritization Speed
The application supports computer-aided triage by algorithmically identifying findings suspicious of a large vessel occlusion and providing notification to the user. Performance testing showed processing times under 110 seconds, with a median of 42 seconds. This helps clinicians prioritize cases more efficiently.
ASPECTS Score Automation
While syngo.CT LVO Detection focuses on LVO, Siemens Healthineers offers syngo.CT ASPECTS, a separate software application that automatically calculates the ASPECT score from non-contrast CT head scans and highlights affected brain regions. This score helps assess the severity of ischemic changes in the MCA regions.
Mobile Notification System
The output from syngo.CT LVO Detection can be sent to an external notification device. Siemens Healthineers' syngo.via WebViewer allows medical professionals to access high-quality multimodality images from anywhere, including on mobile devices, for flexible viewing and reading.
Physician Tip

syngo.CT LVO Detection is a valuable tool for supporting computer-aided triage in stroke cases by quickly identifying suspected large vessel occlusions. It is important to remember that the output is for informational purposes only and not intended for standalone diagnostic use or to alter original medical images. The rapid processing time can aid in prioritizing urgent cases. For a comprehensive stroke evaluation, consider its use in conjunction with other Siemens Healthineers applications like syngo.CT ASPECTS for ischemic change assessment.

syngo.CT LVO Detection runs on the syngo.via platform. The syngo.via platform is a multimodality client-server solution that orchestrates the imaging workflow from acquisition to reading and sharing. It allows for seamless integration with various syngo.via-based software options and can be expanded with additional applications. Cases are automatically prepared and accessible from a quick worklist, with prior studies pre-fetched. The platform also supports accessing images remotely via syngo.via WebViewer.

Details

Category Neurology AI, Radiology & Imaging AI, Triage & ER/ICU AI
Pricing Contact for pricing
DeploymentIntegrated within the syngo.via platform, typically deployed within hospital IT infrastructure (on-premise or hybrid).
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Emergency Medicine, Neurology, Radiology

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2025-04-10K243145 510(k)syngo.CT LVO Detection

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate syngo.CT LVO Detection

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for syngo.CT LVO Detection.

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

syngo.CT LVO Detection is an AI-powered post-processing software that analyzes CT angiography (CTA) images of the brain to help clinicians prioritize cases by detecting suspected large vessel occlusions (LVOs) in specific brain vessels (ICA, M1, and M2 segments). It supports computer-aided triage by notifying users of suspected LVOs, thereby assisting medical professionals in managing stroke patients more efficiently.
syngo.CT LVO Detection is a medical device that has received FDA authorization (K243145) as a radiological computer-assisted triage and notification software. It is intended for informational purposes only and is not for standalone diagnostic use or to alter original medical images. The device is designed to comply with relevant medical device software lifecycle processes, such as IEC 62304.
syngo.CT LVO Detection is intended to support computer-aided triage and identify suspected LVOs; it is not for diagnostic use and does not alter original medical images. It is indicated for patients aged 22 years or older, without contraindications such as old infarcts, other diseases impacting brain vasculature (e.g., brain tumors), metal artifacts (e.g., coils), or surgical signs in the images.
Yes, several other AI-powered LVO detection tools exist, such as Viz LVO, RAPID LVO, CINA LVO, and JLK LVO. These tools utilize various approaches, including traditional machine learning and deep learning models. While some studies compare the performance of different AI tools in terms of sensitivity and specificity, direct comparative data for syngo.CT LVO Detection against all alternatives is not readily available in the provided search results.
syngo.CT LVO Detection runs on the syngo.via platform. The syngo.via platform is a multimodality reading solution that can be integrated into RIS/PACS workstations from major vendors, allowing for advanced visualization and quantification functionality. This integration enables the software to make case-level output available to a CT scanner or other PACS system for worklist prioritization.
Performance testing of syngo.CT LVO Detection on 602 retrospective CT datasets demonstrated a sensitivity of 90.6% and a specificity of 88.8% for LVO detection. These results exceeded predefined acceptance criteria and were consistent across diverse patient demographics, multiple CT manufacturers, and various image quality ranges.

Related Tools

syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
Neurophet AQUA AD Plus
Neurophet
Neurology AI
Neurophet AQUA AD Plus is an AI-powered brain imaging analysis software that supports the diagnosis, treatment guidance, and monitoring of Alzheimer's disease by analyzing MRI and PET scans.
myosmart trial kit
Otto Bock Healthcare Products GmbH
Neurology AI
The Ottobock MyoSmart Trial Kit assists clinicians in assessing and fitting advanced neurorehabilitation prosthetic and orthotic solutions.
connectgrip. (560X27-1)
Otto Bock Healthcare Products GmbH
Neurology AI
Otto Bock Healthcare Products GmbH offers advanced prosthetic and orthotic solutions, with 'connectgrip' (560X27-1) likely being a component designed for secure and functional connection within these systems, potentially incorporating intelligent features for enhanced user control.
myosmart.cuff (757M20-2)
Otto Bock Healthcare Products GmbH
Lab & Diagnostics
The myosmart.cuff is a medical device by Otto Bock Healthcare Products GmbH designed for objective measurement of muscle tone, primarily for use in neurological rehabilitation.
myosmart. (13E522)
Otto Bock Healthcare Products GmbH
Neurology AI
myosmart.

See all Neurology AI tools →

More from Siemens Medical Solutions USA

ACUSON Origin Diagnostic Ultrasound System
Siemens Medical Solutions USA, Inc.
Cardiology AI
The ACUSON Origin Diagnostic Ultrasound System by Siemens Healthineers offers AI-powered cardiovascular imaging for enhanced diagnostic confidence and workflow efficiency.
ACUSON Sequoia Diagnostic Ultrasound System
Siemens Healthineers
Radiology & Imaging AI
The ACUSON Sequoia Diagnostic Ultrasound System by Siemens Healthineers is a premium platform featuring BioAcoustic imaging, InFocus technology, and AI-powered tools to deliver consistent, high-resolution ultrasound imaging across diverse patient types and clinical applications.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System
Siemens Medical Solutions USA
Cardiology AI
Siemens Healthineers offers the ACUSON Sequoia, ACUSON Sequoia Select, and ACUSON Origin ultrasound systems, providing advanced imaging for various medical needs. The Sequoia line focuses on high-resolution imaging with deep penetration and reduced variability, while the AI-powered ACUSON Origin specializes in comprehensive cardiovascular diagnostics and interventions.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System, ACUSON Origin ICE Diagnostic Ultrasound System
Siemens Medical Solutions, USA
Cardiology AI
Siemens Healthineers offers advanced AI-powered ultrasound systems, including the ACUSON Origin for comprehensive cardiovascular care and the ACUSON Sequoia for high-performance general imaging with BioAcoustic™ technology.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-14 | First Added: 2026-04-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.